ADIPOQ and atrial fibrillation: The associations of adiponectin with all-cause and cardiovascular mortality shifted from a U-shaped relationship for participants free of prevalent clinical cardiovascular disease (including congestive heart failure) after extensively adjusting for potential confounders to a direct linear association for individuals with prevalent heart failure or atrial fibrillation.